- Home
- Our People
- Teaching, Research and Support
- Bruce Russell
Professor Bruce Russell
Current research:
Vivax Malaria (or Relapsing Malaria) is the most widely distributed, difficult to diagnose and treat cause of human malaria.
Our laboratory focuses in of the biology of the parasite Plasmodium vivax (the cause of vivax malaria) and how we can kill it using therapeutics or vaccinations.
To do this we have developed key ex vivo tools and methods to examine P. vivax drug susceptibility and reticulocyte invasion. These methods are optimised for use in malaria endemic regions. We also utilise a continuous culture of P. cynomolgi (an excellent model of P. vivax) to study the molecular mechanisms underlying P. vivax pathobiology.
In addition to vivax malaria we also contend research into the biology and epidemiology of protozoal parasites of importance to human health in New Zealand.
Key laboratory activities
1. MALARIA
- Developing effective medical products (antimalarials and antiprotozoal drugs) and research tools (diagnostic and surveillance) for resource poor locations with the view to control vector borne diseases such as malaria and dengue; as well as other parasitic diseases of importance to human health.
- Better understanding the pathobiology, antimalarial sensitivity profiles and Epidemiology of Plasmodium vivax and other important primate malarias (P. cynomolgi, P. knowlesi and P. coatneyi)
- Detailed studies of the biomechanical, cytoadhesive and nanostructure changes to red blood cell pre and post Plasmodium spp. infection
2. CRYPTOSPORIDIOSIS (Team Leader Dr Remy Muhsin)
- Fundamental biology of Cryptosporidium spp.
- Cryptosporidiosis drug discovery and development
Parasitology Lab 2021
Current group members
Post Doctoral Staff
Postgraduate students
Recent publications (2019-2024)
-
-
Antiparasitic effect of peptoids againstCryptosporidium parvum
2024-07-19 | preprint
-
-
Functional and immunological mapping of domains of the reticulocyte binding protein, <i>Plasmodium vivax</i> PvRBP2aThe Journal of Infectious Diseases
2024-03-05 | journal-article
-
-
Comparative efficacy and safety of anti-cryptosporidial agents: An<i>in vitro</i>study on Nitazoxanide, HFL, KDU731, and Paromomycin against<i>Cryptosporidium parvum</i>
2024-02 | preprint
Source: Bruce Russell via Europe PubMed Central
-
-
Extended blood stage sensitivity profiles of<i>Plasmodium vivax</i>to doxycycline and tafenoquine using<i>Plasmodium cynomolgi</i>as a model
2024-02 | preprint
Source: Bruce Russell via Europe PubMed Central
-
-
Dientamoeba fragilis associated with microbiome diversity changes in acute gastroenteritis patients.Parasitology international
2023-07 | journal-article
Source: Bruce Russell via Europe PubMed Central
-
-
Favorable Preclinical Pharmacological Profile of a Novel Antimalarial Pyrrolizidinylmethyl Derivative of 4-amino-7-chloroquinoline with Potent In Vitro and In Vivo Activities.Biomolecules
2023-05 | journal-article
Source: Bruce Russell via Europe PubMed Central
-
-
Integrative genetic manipulation of Plasmodium cynomolgi reveals MultiDrug Resistance-1 Y976F associated with increased in vitro susceptibility to mefloquine.
2022-12-01 | other
-
-
Evolving perspectives on rosetting in malariaTrends in Parasitology
2022-10 | journal-article
-
-
Erythrocyte tropism of malarial parasites: The reticulocyte appealFrontiers in Microbiology
2022 | journal-article
Source: Bruce Russell via Scopus - Elsevier
-
-
Geographical distribution and genetic diversity of Plasmodium vivax reticulocyte binding protein 1a correlates with patient antigenicityPLoS Neglected Tropical Diseases
2022 | journal-article
Source: Bruce Russell via Scopus - Elsevier
-
-
Improving in vitro continuous cultivation of Plasmodium cynomolgi, a model for P. vivaxParasitology International
2022 | journal-article
Source: Bruce Russell via Scopus - Elsevier
-
-
Rosetting Responses of Plasmodium-infected Erythrocytes to AntimalarialsAmerican Journal of Tropical Medicine and Hygiene
2022 | journal-article
Source: Bruce Russell via Scopus - Elsevier
-
-
Ultrastructural characterization of host-parasite interactions of Plasmodium coatneyi in rhesus macaquesParasitology
2022 | journal-article
Source: Bruce Russell via Scopus - Elsevier
-
-
A chimeric plasmodium vivax merozoite surface protein antibody recognizes and blocks erythrocytic P. cynomolgi berok merozoites in vitroInfection and Immunity
2021 | journal-article
Source: Bruce Russell via Scopus - Elsevier
-
-
Evaluation of splenic accumulation and colocalization of immature reticulocytes and Plasmodium vivax in asymptomatic malaria: A prospective human splenectomy studyPLoS Medicine
2021 | journal-article
Source: Bruce Russell via Scopus - Elsevier
-
-
Hidden biomass of intact malaria parasites in the human spleenNew England Journal of Medicine
2021 | journal-article
Source: Bruce Russell via Scopus - Elsevier
-
-
Longitudinal ex vivo and molecular trends of chloroquine and piperaquine activity against Plasmodium falciparum and P. vivax before and after introduction of artemisinin-based combination therapy in Papua, IndonesiaInternational Journal for Parasitology: Drugs and Drug Resistance
2021 | journal-article
Source: Bruce Russell via Scopus - Elsevier
-
-
Plasmodium falciparum rosetting protects schizonts against artemisinineBioMedicine
2021 | journal-article
Source: Bruce Russell via Scopus - Elsevier
-
-
Plasmodium vivax binds host CD98hc (SLC3A2) to enter immature red blood cellsNature Microbiology
2021 | journal-article
Source: Bruce Russell via Scopus - Elsevier
-
-
Probing the distinct chemosensitivity of Plasmodium vivax liver stage parasites and demonstration of 8-aminoquinoline radical cure activity in vitroResearchSquare
2021 | other
Source: Bruce Russell via Scopus - Elsevier
-
-
Probing the distinct chemosensitivity of Plasmodium vivax liver stage parasites and demonstration of 8-aminoquinoline radical cure activity in vitroScientific Reports
2021 | journal-article
Source: Bruce Russell via Scopus - Elsevier
-
-
Genetic diversity and neutral selection in Plasmodium vivax erythrocyte binding protein correlates with patient antigenicityPLoS Neglected Tropical Diseases
2020 | journal-article
Source: Bruce Russell via Scopus - Elsevier
-
-
Plasmodium-infected erythrocytes induce secretion of IGFBP7 to form type ii rosettes and escape phagocytosiseLife
2020 | journal-article
Source: Bruce Russell via Scopus - Elsevier
-
-
Rosettes integrity protects Plasmodium vivax of being phagocytizedScientific Reports
2020 | journal-article
Source: Bruce Russell via Scopus - Elsevier
-
-
Inhibition of parasite invasion by monoclonal antibody against epidermal growth factor-like domain of Plasmodium vivax merozoite surface protein 1 paralogScientific Reports
2019-12 | journal-article
-
-
Sticking for a Cause: The Falciparum Malaria Parasites Cytoadherence ParadigmFrontiers in Immunology
2019-06-27 | journal-article
-
-
Hepatic spheroids used as an in vitro model to study malaria relapseBiomaterials
2019 | journal-article
Source: Web of Science Researcher Profile Sync
-
-
In vitro antimalarial evaluations and cytotoxicity investigations of carica papaya leaves and carpaineNatural Product Communications
2019 | journal-article
Source: Bruce Russell via Scopus - Elsevier
-
-
Robust continuous in vitro culture of the Plasmodium cynomolgi erythrocytic stagesNature Communications
2019 | journal-article
Source: Bruce Russell via Scopus - Elsevier
-
-
Structural basis for inhibition of Plasmodium vivax invasion by a broadly neutralizing vaccine-induced human antibodyNature Microbiology
2019 | journal-article
Source: Web of Science Researcher Profile Sync